Mon: TASE opens holiday week lower
Palo Alto Networks led the declines on the Tel Aviv 35 Index while Tower bucked the market.
We haven't written up this one. Globes English has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
Palo Alto Networks led the declines on the Tel Aviv 35 Index while Tower bucked the market.
We haven't written up this one. Globes English has the full story — the link below goes straight to it.
IonQ has "multiple ways to win" but investors are paying for growth that is not yet realized.
IonQ has "multiple ways to win" but investors are paying for growth that is not yet realized.
Moderna has the clinical lead, while BioNTech has the deeper war chest. See which cancer stock offers the stronger long-term setup as mRNA oncology enters a new phase.
The rate of payments-related revenue growth in North America, and globally, will slow in the next four years, a major consulting firm predicts.